Amínóheteróarýl efnasambönd sem prótín kínasa hindrar

Aminopyridine and aminopyrazine compounds of formula (1), compositions including these compounds, and methods of their use are provided. Preferred compounds of formula 1 have activity as protein kinase inhibitors, including as inhibitors of c-MET.

Saved in:
Bibliographic Details
Main Authors FANG-JIE ZHANG, MITCHELL DAVID NAMBU, ALLISON WALTER, MASON ALAN PAIRISH, LEE A. FUNK, JERRY JIALUN MENG, JOANNE JOHNSON, PEI-PEI KUNG, XIAOYUAN (SHARON) LI, CHRISTOPHER G. NELSON, JINGJONG JEAN CUI, DILIP BHUMRALKAR, JENNIFER ZHANG, CATHLEEN ELIZABETH HANAU, G. DAVIS HARRIS JR, JASON (QISHEN) LIN, IRINY BOTROUS, MICHELLE TRAN-DUBE, LEI JIA, STEPHEN A. KOLODZIEJ, JI YU CHU, HONG SHEN
Format Patent
LanguageIcelandic
Published 18.08.2005
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Aminopyridine and aminopyrazine compounds of formula (1), compositions including these compounds, and methods of their use are provided. Preferred compounds of formula 1 have activity as protein kinase inhibitors, including as inhibitors of c-MET.
Bibliography:Application Number: IS20050007990